logo
Tomato Recall Update as FDA Issues Highest Warning Level

Tomato Recall Update as FDA Issues Highest Warning Level

Newsweek29-05-2025

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
The Food and Drug Administration (FDA) has issued its highest risk level for a tomato recall involving potential salmonella contamination.
Williams Farms Repack LLC initiated the recall on April 29 after Southeast Tomato Distributors notified it of a potential salmonella contamination from H&C Farms.
Newsweek contacted Williams Farms Repack LLC via phone outside of regular hours on Friday.
Why It Matters
The recall affects shipments of fresh tomatoes reaching retailers and distributors in several U.S. states. Salmonella can cause severe illness, particularly in children, the elderly and those with weakened immune systems.
Salmonella infection, or salmonellosis, can trigger symptoms such as diarrhea, abdominal cramps, fever, nausea, vomiting and dehydration within six to 72 hours of exposure. While most individuals recover after four to seven days, severe complications are possible, especially for individuals in vulnerable groups. The FDA cautioned that rare cases can escalate to illnesses such as arterial infections or endocarditis.
The Centers for Disease Control and Prevention has estimated that salmonella causes about 420 deaths annually in the U.S.
A photo of the affected product in the Williams Farms Repack LLC recall.
A photo of the affected product in the Williams Farms Repack LLC recall.
Williams Farms Repack LLC
What To Know
On Wednesday, the FDA designated the recall as Class I, warning that exposure may lead to serious or even fatal health outcomes.
The recall covers shipments from April 23 to April 28, and the affected tomatoes reached consumers in Georgia and the Carolinas.
The affected products include multiple packaging formats: 5x6 25lb, 6x6 25lb, Combo 25lb, 4x4 2layer, 4x5 2layer, 60ct 2layer, 60ct 18lb loose, XL 18lb Loose and 3ct trays with UPC 0 33383 65504 8. The lot numbers are R4467 and R4470.
According to the initial recall, there have been no reported illnesses linked to these products.
What People Are Saying
Jeongmin Song, professor of microbiology & immunology at Cornell University, New York, previously told Newsweek: "Generally speaking, picking and packaging produce at the farm and the facility can result in food contamination. Some potential causes include polluted fertilizers and fomites at the packing facilities, while there are many plausible explanations. Although food and facility contaminations, such as the recent cases, do occur occasionally, they are uncommon in the U.S. and other developed countries owing to strict hygiene standards."
She added: "Healthy individuals with robust immune systems can recover from a Salmonella infection even after consumption. However, some vulnerable groups, such as young children, the elderly, or those with weakened immune systems, would be at risk from contaminated products. Even if there was Salmonella on the tomatoes, most contaminated bacteria can be eliminated by washing them before consumption."
The Food and Drug Administration said on its website: "When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company."
The Centers for Disease Control and Prevention's guidance on salmonella said: "In some people, the illness may be so severe that the patient is hospitalized. Salmonella infection may spread from the intestines to the bloodstream and then to other parts of the body."
What Happens Next
The FDA lists the recall as ongoing. Consumers are advised to check lot numbers and discard any affected tomatoes. Products may be returned for a full refund or disposed of to prevent illness. Customers with questions can contact Jason Breland at 843-866-7707 or 843-599-5154 from 8 a.m. to 5 p.m. ET Monday to Friday.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ProZenith Launches Natural Supplement Formulated for Weight Management Support
ProZenith Launches Natural Supplement Formulated for Weight Management Support

Business Upturn

timean hour ago

  • Business Upturn

ProZenith Launches Natural Supplement Formulated for Weight Management Support

By GlobeNewswire Published on June 7, 2025, 06:50 IST Aurora, June 06, 2025 (GLOBE NEWSWIRE) — ProZenith recently announced the launch of its new wellness supplement developed to assist individuals in maintaining energy, focus, and mindful appetite awareness as part of a balanced and active lifestyle. Manufactured in the United States in a facility that is FDA-registered and GMP-certified, the product is now available through official online channels. ProZenith is intended for individuals pursuing support for general weight management and overall well-being. Its formulation includes select ingredients chosen to align with healthy routines and support individuals seeking help managing non-hunger-related snacking behaviors. Each purchase of ProZenith is covered by a 60-day refund policy, reflecting the company's customer-first return assurance framework. All ProZenith supplements are manufactured without genetically modified ingredients and adhere to U.S. quality standards. Production takes place in an FDA-registered facility that complies with current Good Manufacturing Practices (cGMP). ProZenith is currently available through the company's official online platform at with multiple purchase options provided for convenience. About ProZenith ProZenith develops nutritional supplements designed to support individuals on their wellness journeys. The company emphasizes high-quality manufacturing, transparency, and customer satisfaction as it continues to expand its product offerings for health-conscious consumers. For customer support inquiries, contact: [email protected] Disclaimer: This product has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Media Contact: Company: ProZenith ProZenith Address: 19655 E 35th Dr #100, Aurora, CO 80011 19655 E 35th Dr #100, Aurora, CO 80011 Email: [email protected] [email protected] Order Phone Support: (925) 217-7353 Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.

RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results
RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results

Yahoo

time2 hours ago

  • Yahoo

RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results

On Thursday, Ascendiant analyst Edward Woo raised the price target on RenovoRx Inc. (NASDAQ:RNXT) to $11.50 from $11, while maintaining a Buy rating on the shares. This adjustment follows the company's strong revenue growth reported in its Q1 2025 results. Woo indicated that the commercialization of RenovoCath and anticipated positive clinical data in Q3 will serve as strong catalysts for the stock. A clinical researcher in a lab examining a new biopharmaceutical product. The Q1 result includes ~$200K in revenue from commercial sales of RenovoCath alone. RenovoCath is an FDA-cleared and dual-balloon catheter device for the targeted isolation of blood flow and delivery of fluids. R&D expenses increased to $1.7 million, up from $1.3 million in Q1 2024, which was driven by higher employee compensation and manufacturing costs during the quarter. The company's Phase 3 TIGeR-PaC clinical trial showed promising results, with patients experiencing a median overall survival of 16 months using their targeted approach compared to 10 months with standard chemotherapy. There was also a 65% reduction in adverse events like nausea and fatigue. This trial is evaluating the company's proprietary TAMP therapy platform for the treatment of Locally Advanced Pancreatic Cancer. RenovoRx Inc. (NASDAQ:RNXT) is a clinical-stage biopharmaceutical company that develops targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment. While we acknowledge the potential of RNXT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

ProZenith Launches Natural Supplement Formulated for Weight Management Support
ProZenith Launches Natural Supplement Formulated for Weight Management Support

Yahoo

time6 hours ago

  • Yahoo

ProZenith Launches Natural Supplement Formulated for Weight Management Support

U.S.-Made Product Supports General Wellness Goals with a 60-Day Refund Policy Aurora, June 06, 2025 (GLOBE NEWSWIRE) -- ProZenith recently announced the launch of its new wellness supplement developed to assist individuals in maintaining energy, focus, and mindful appetite awareness as part of a balanced and active lifestyle. Manufactured in the United States in a facility that is FDA-registered and GMP-certified, the product is now available through official online channels. ProZenith is intended for individuals pursuing support for general weight management and overall well-being. Its formulation includes select ingredients chosen to align with healthy routines and support individuals seeking help managing non-hunger-related snacking behaviors. Each purchase of ProZenith is covered by a 60-day refund policy, reflecting the company's customer-first return assurance framework. All ProZenith supplements are manufactured without genetically modified ingredients and adhere to U.S. quality standards. Production takes place in an FDA-registered facility that complies with current Good Manufacturing Practices (cGMP). ProZenith is currently available through the company's official online platform at with multiple purchase options provided for convenience. About ProZenith ProZenith develops nutritional supplements designed to support individuals on their wellness journeys. The company emphasizes high-quality manufacturing, transparency, and customer satisfaction as it continues to expand its product offerings for health-conscious consumers. For customer support inquiries, contact:support@ Disclaimer:This product has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Media Contact: Company: ProZenith Address: 19655 E 35th Dr #100, Aurora, CO 80011 Email: support@ Order Phone Support: (925) 217-7353 CONTACT: Company: ProZenith Address: 19655 E 35th Dr #100, Aurora, CO 80011 Email: support@ Order Phone Support: (925) 217-7353Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store